Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

88 structures for P28070

Entry ID Method Resolution Chain Position Source
4R3O X-ray 260 A 2/N 46-262 PDB
4R67 X-ray 289 A 2/N/b/p 46-262 PDB
5A0Q EM 350 A N/b 46-264 PDB
5GJQ EM 450 A g/u 1-264 PDB
5GJR EM 350 A g/u 1-264 PDB
5L4G EM 402 A 4/X 1-264 PDB
5LE5 X-ray 180 A M/a 46-264 PDB
5LEX X-ray 220 A M/a 46-264 PDB
5LEY X-ray 190 A M/a 46-264 PDB
5LEZ X-ray 219 A M/a 46-264 PDB
5LF0 X-ray 241 A M/a 46-264 PDB
5LF1 X-ray 200 A M/a 46-264 PDB
5LF3 X-ray 210 A M/a 46-264 PDB
5LF4 X-ray 199 A M/a 46-264 PDB
5LF6 X-ray 207 A M/a 46-264 PDB
5LF7 X-ray 200 A M/a 46-264 PDB
5LN3 EM 680 A 7 1-264 PDB
5M32 EM 380 A M/a 1-264 PDB
5T0C EM 380 A AT/BT 2-264 PDB
5T0G EM 440 A T 2-264 PDB
5T0H EM 680 A T 2-264 PDB
5T0I EM 800 A T 2-264 PDB
5T0J EM 800 A T 2-264 PDB
5VFO EM 350 A T/t 46-260 PDB
5VFP EM 420 A T/t 46-260 PDB
5VFQ EM 420 A T/t 46-260 PDB
5VFR EM 490 A T/t 46-260 PDB
5VFS EM 360 A T/t 46-260 PDB
5VFT EM 700 A T/t 46-260 PDB
5VFU EM 580 A T/t 46-260 PDB
6AVO EM 380 A W/a 46-264 PDB
6E5B X-ray 277 A M/a 1-264 PDB
6KWY EM 272 A M/a 1-264 PDB
6MSB EM 300 A T/t 2-264 PDB
6MSD EM 320 A T/t 2-264 PDB
6MSE EM 330 A B 108-158 PDB
6MSG EM 350 A T/t 2-264 PDB
6MSH EM 360 A T/t 2-264 PDB
6MSJ EM 330 A T/t 2-264 PDB
6MSK EM 320 A T/t 2-264 PDB
6R70 EM 350 A M/a 46-261 PDB
6REY EM 300 A N/b 46-264 PDB
6RGQ EM 260 A N/b 46-264 PDB
6WJD EM 480 A T/t 2-264 PDB
6WJN EM 570 A T/t 46-260 PDB
6XMJ EM 300 A N 46-262 PDB
7AWE X-ray 229 A N/b 46-259 PDB
7B12 X-ray 243 A 2/N 46-259 PDB
7LXV EM 340 A M/a 46-264 PDB
7NAN EM 280 A M/a 1-264 PDB
7NAO EM 290 A M/a 1-264 PDB
7NAP EM 320 A M/a 1-264 PDB
7NAQ EM 320 A M/a 1-264 PDB
7NHT EM 280 A M 1-264 PDB
7PG9 EM 370 A N/b 46-264 PDB
7QXN EM 370 A T/t 2-264 PDB
7QXP EM 360 A T/t 2-264 PDB
7QXU EM 430 A T/t 2-264 PDB
7QXW EM 410 A T/t 2-264 PDB
7QXX EM 440 A T/t 2-264 PDB
7QY7 EM 470 A T/t 2-264 PDB
7QYA EM 480 A T/t 2-264 PDB
7QYB EM 410 A T/t 2-264 PDB
7V5G EM 447 A G/N 46-264 PDB
7V5M EM 388 A N/b 46-264 PDB
7W37 EM 300 A T/t 1-264 PDB
7W38 EM 310 A T/t 1-264 PDB
7W39 EM 320 A T/t 1-264 PDB
7W3A EM 350 A T/t 1-264 PDB
7W3B EM 360 A T/t 1-264 PDB
7W3C EM 340 A T/t 1-264 PDB
7W3F EM 330 A T/t 1-264 PDB
7W3G EM 320 A T/t 1-264 PDB
7W3H EM 320 A T/t 1-264 PDB
7W3I EM 350 A T/t 1-264 PDB
7W3J EM 350 A T/t 1-264 PDB
7W3K EM 360 A T/t 1-264 PDB
7W3M EM 350 A T/t 1-264 PDB
8BZL X-ray 214 A M/a 1-264 PDB
8CVR EM 270 A N/b 1-264 PDB
8CVS EM 310 A M/a 1-264 PDB
8CVT EM 300 A T/t 1-264 PDB
8CXB EM 290 A M/a 1-264 PDB
8QYN EM 288 A P 1-264 PDB
8QYO EM 284 A M/a 1-264 PDB
8QYS EM 389 A P/g 50-257 PDB
8UD9 EM 204 A N/b 46-264 PDB
AF-P28070-F1 Predicted AlphaFoldDB

235 variants for P28070

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1235715459
RCV000663377
RCV002530604
16 P>missing Proteasome-associated autoinflammatory syndrome 3 [ClinVar] Yes ClinVar
dbSNP
RCV001335065
RCV002547334
rs777632466
CA1090660
RCV002546711
158 G>R Proteasome-associated autoinflammatory syndrome 3 Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000663375
rs1553209362
212 D>missing Proteasome-associated autoinflammatory syndrome 3 [ClinVar] Yes ClinVar
dbSNP
VAR_075255 212 D>del PRAAS3; decreased protein maturation; changed proteasome assembly; poor incorporation into 20S and 26S proteasomes [UniProt] Yes UniProt
RCV000663378
CA341926961
rs1553209373
222 Y>* Proteasome-associated autoinflammatory syndrome 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
VAR_081126 222 Y>del PRAAS3; digenic inheritance; patient also carries a mutation in PSMB8; no effect on protein abundance; changed proteasome assembly; poor incorporation into 20S and 26S proteasomes [UniProt] Yes UniProt
rs372329683
CA29562840
3 A>V No ClinGen
TOPMed
gnomAD
TCGA novel 4 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA29562849
rs916235342
5 L>* No ClinGen
TOPMed
rs916235342
CA341918909
5 L>W No ClinGen
TOPMed
rs1311094184
CA341918941
6 G>V No ClinGen
gnomAD
CA1090551
rs780723106
7 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1049463156
CA29562867
8 R>P No ClinGen
TOPMed
gnomAD
rs1049463156
CA341918975
8 R>Q No ClinGen
TOPMed
gnomAD
CA29562856
rs11557384
8 R>W No ClinGen
gnomAD
CA341918987
rs768718256
9 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs768718256
CA1090553
COSM675462
9 S>F lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA341919002
rs1205598659
10 G>A No ClinGen
TOPMed
CA1090554
rs11557386
10 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs748325633
CA1090555
12 W>* No ClinGen
ExAC
gnomAD
CA29562887
rs770030168
13 A>E No ClinGen
ExAC
TOPMed
RCV001310536
CA1090556
rs770030168
13 A>V No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
CA341919102
rs1415641906
CA341919105
14 G>R No ClinGen
gnomAD
CA341919119
rs111502283
15 G>C No ClinGen
ExAC
TOPMed
gnomAD
CA341919140
rs1442613005
15 G>D No ClinGen
TOPMed
CA1090558
rs111502283
15 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA341919136
rs111502283
15 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs1442613005
CA341919143
15 G>V No ClinGen
TOPMed
TCGA novel 16 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771817722
CA1090559
16 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs760532671
CA341919169
17 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA1090561
rs760532671
17 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA341919186
rs1300175557
17 A>V No ClinGen
TOPMed
gnomAD
CA29562913
rs545969743
18 P>S No ClinGen
1000Genomes
TCGA novel 19 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753420632
CA1090563
20 Q>R No ClinGen
ExAC
gnomAD
CA341919350
rs1571304612
22 Y>S No ClinGen
Ensembl
COSM1639499
CA1090565
rs115066321
23 R>H stomach [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
gnomAD
CA1090564
rs761449014
23 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA341919423
rs1241669036
26 S>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs1381259372
CA341919430
27 T>A No ClinGen
gnomAD
CA341919450
rs1286156033
27 T>I No ClinGen
gnomAD
CA1090567
rs758828536
29 D>N No ClinGen
ExAC
gnomAD
CA1090568
rs780283759
31 F>L No ClinGen
ExAC
TOPMed
rs752044137
CA1090569
32 M>K No ClinGen
ExAC
TOPMed
gnomAD
CA29562968
rs752044137
32 M>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 33 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs898282852
CA29562976
34 P>L No ClinGen
TOPMed
gnomAD
rs898282852
CA341919610
34 P>Q No ClinGen
TOPMed
gnomAD
TCGA novel 34 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1050423331
CA29562986
36 S>F No ClinGen
TOPMed
gnomAD
CA29562997
rs113331137
41 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA29562993
rs375090204
41 G>S No ClinGen
Ensembl
CA1090571
rs113331137
41 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM3801826
rs1160503000
CA341919779
42 P>A Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA341919780
rs1160503000
42 P>S No ClinGen
gnomAD
rs748199140
CA1090572
44 T>P No ClinGen
ExAC
gnomAD
rs1308655589
CA341919913
47 Q>R No ClinGen
TOPMed
rs757443666
CA1090597
50 M>I No ClinGen
ExAC
gnomAD
CA1090598
rs779858337
51 V>L No ClinGen
ExAC
gnomAD
rs746758423
CA1090599
52 T>I No ClinGen
ExAC
gnomAD
CA341920332
rs1380433434
58 G>A No ClinGen
gnomAD
CA341920333
rs1020706621
59 V>I No ClinGen
TOPMed
CA29563264
rs1020706621
59 V>L No ClinGen
TOPMed
rs1571304868
CA341920592
62 E>D No ClinGen
Ensembl
rs371543427
CA1090602
67 I>M No ClinGen
ESP
ExAC
gnomAD
rs1171898856
CA341920775
69 A>V No ClinGen
gnomAD
rs11557388
CA29563283
70 D>E No ClinGen
Ensembl
TCGA novel 71 M>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1295271311
CA341920891
74 S>Y No ClinGen
TOPMed
rs1415482883
CA889335806
75 Y>* No ClinGen
TOPMed
CA1090603
rs199924460
75 Y>N No ClinGen
1000Genomes
ExAC
gnomAD
rs772867689
COSM224171
CA1090605
77 S>F skin [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs762622171
CA1090607
80 R>C No ClinGen
ExAC
gnomAD
CA1090606
rs762622171
80 R>S No ClinGen
ExAC
gnomAD
TCGA novel 82 R>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 82 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1090609
rs759810305
83 N>H No ClinGen
ExAC
gnomAD
rs373620750
CA1090610
83 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs753138351
CA1090613
84 I>M No ClinGen
ExAC
gnomAD
CA1090611
rs1553209137
84 I>V No ClinGen
Ensembl
CA341921260
rs1332469735
86 R>C No ClinGen
TOPMed
TCGA novel 86 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764111801
CA1090615
88 M>I No ClinGen
ExAC
gnomAD
TCGA novel 89 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1229910486
CA341921358
89 R>Q No ClinGen
gnomAD
CA341921500
CA1090617
rs757407255
92 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs1216068220
CA341921506
93 S>G No ClinGen
gnomAD
rs1043321002
CA29563335
94 T>I No ClinGen
TOPMed
gnomAD
rs1804241
VAR_012072
CA29563339
CA1090620
95 M>I No ClinGen
ExAC
gnomAD
UniProt
dbSNP
CA1090619
rs746166868
95 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs1571304933
CA341921624
96 L>V No ClinGen
Ensembl
CA341921656
rs1368213434
97 G>A No ClinGen
gnomAD
rs11557387
CA29563340
97 G>S No ClinGen
Ensembl
CA1090621
rs781145839
98 A>T No ClinGen
ExAC
gnomAD
CA341921763
COSM1295050
rs1415169682
101 D>N Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 102 Y>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1090623
rs769879926
103 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs1286813369
CA341921994
105 F>C No ClinGen
gnomAD
rs1295872154
CA341922014
106 Q>L No ClinGen
gnomAD
rs777893016
CA1090624
107 Y>C No ClinGen
ExAC
gnomAD
rs1557854444
CA341922139
110 Q>H No ClinGen
Ensembl
rs1400271177
CA341922138
110 Q>R No ClinGen
gnomAD
CA341922174
rs1333119600
112 L>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA1090627
rs372581320
113 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs568410343
CA1090628
114 Q>R No ClinGen
1000Genomes
ExAC
gnomAD
rs759234136
CA1090629
115 M>V No ClinGen
ExAC
gnomAD
CA29563521
rs933171351
117 I>M No ClinGen
TOPMed
gnomAD
CA1090646
rs778500444
119 E>K No ClinGen
ExAC
gnomAD
CA341923588
rs1379137718
122 L>V No ClinGen
gnomAD
CA341923667
rs1285532281
125 G>E No ClinGen
TOPMed
rs745464020
CA1090647
126 H>Q No ClinGen
ExAC
gnomAD
TCGA novel 126 H>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771743580
CA1090648
127 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs1571305083
CA341923750
127 S>I No ClinGen
Ensembl
rs775164354
CA1090649
128 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA1090650
rs761013630
131 R>K No ClinGen
ExAC
gnomAD
CA1090652
rs776935448
133 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA341924141
rs1240575919
139 R>M No ClinGen
gnomAD
rs762393225
CA1090653
141 M>L No ClinGen
ExAC
gnomAD
CA341924196
rs1197614988
141 M>T No ClinGen
gnomAD
rs765179156
CA1090654
142 Y>* No ClinGen
ExAC
gnomAD
rs910660327
CA29563582
142 Y>F No ClinGen
Ensembl
rs201438006
CA29563571
142 Y>H No ClinGen
Ensembl
CA341924232
rs910660327
142 Y>S No ClinGen
Ensembl
rs750544134
CA1090655
143 S>T No ClinGen
ExAC
TOPMed
gnomAD
CA29563594
rs140771260
144 R>Q No ClinGen
ESP
CA29563593
rs367717074
144 R>W No ClinGen
ESP
TOPMed
TCGA novel 145 R>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1090656
rs763162526
149 N>K No ClinGen
ExAC
gnomAD
CA29563597
rs3209764
149 N>Y No ClinGen
Ensembl
CA341924478
rs1333211778
151 L>V No ClinGen
gnomAD
CA341924618
rs371316814
156 V>I No ClinGen
Ensembl
rs371316814
RCV001338577
CA29563602
156 V>L No ClinGen
ClinVar
Ensembl
dbSNP
CA1090659
rs751892201
157 I>M No ClinGen
ExAC
gnomAD
CA341924685
rs1340637901
158 G>A No ClinGen
TOPMed
rs894848845
CA29563611
160 Y>C No ClinGen
TOPMed
rs753664008
CA1090661
160 Y>H No ClinGen
ExAC
TOPMed
gnomAD
CA1090662
rs757243651
161 A>T No ClinGen
ExAC
gnomAD
rs778248319
CA1090663
161 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA341924804
rs3209765
163 G>E No ClinGen
TOPMed
gnomAD
CA1090664
rs745352663
165 S>C No ClinGen
ExAC
gnomAD
CA1090684
rs757837361
168 G>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 172 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA341925262
rs1419921260
173 L>H No ClinGen
TOPMed
gnomAD
rs1419921260
CA341925264
173 L>R No ClinGen
TOPMed
gnomAD
CA1090686
rs746614860
174 G>R No ClinGen
ExAC
gnomAD
CA341925347
rs1370187294
176 A>P No ClinGen
gnomAD
CA29563884
rs993355830
177 Y>C No ClinGen
Ensembl
CA341925485
rs1236846242
180 P>A No ClinGen
TOPMed
CA1090689
rs11557382
181 S>L No ClinGen
ExAC
TOPMed
gnomAD
COSM895800
rs866266207
CA29563927
183 A>T endometrium [Cosmic] No ClinGen
cosmic curated
Ensembl
CA1090690
rs748519387
183 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA341925603
rs1290875646
184 T>S No ClinGen
gnomAD
CA29563941
rs11557385
186 Y>C No ClinGen
Ensembl
rs3209715
CA29563947
190 L>F No ClinGen
Ensembl
CA341925832
rs770110723
191 A>G No ClinGen
ExAC
TOPMed
gnomAD
rs770110723
CA1090691
191 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs773855644
CA1090692
192 Q>H No ClinGen
ExAC
gnomAD
rs762773006
CA1090720
193 P>T No ClinGen
ExAC
gnomAD
rs766279607
CA1090721
195 L>M No ClinGen
ExAC
TOPMed
gnomAD
CA1090722
rs372714296
196 R>* No ClinGen
ESP
ExAC
gnomAD
CA1090723
rs759078385
196 R>Q No ClinGen
ExAC
TOPMed
rs570825621
CA341926144
197 E>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1090725
rs539703644
197 E>D No ClinGen
1000Genomes
ExAC
gnomAD
rs570825621
CA1090724
197 E>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA341926160
rs1331187901
198 V>F No ClinGen
TOPMed
gnomAD
CA341926152
rs1331187901
198 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA1090726
rs755747531
199 L>P No ClinGen
ExAC
gnomAD
CA29564264
rs553152067
200 E>G No ClinGen
1000Genomes
rs1571305999
CA341926226
201 K>N No ClinGen
Ensembl
rs778245626
CA29564269
204 V>A No ClinGen
ExAC
TOPMed
gnomAD
CA1090727
rs778245626
204 V>G No ClinGen
ExAC
TOPMed
gnomAD
rs1251817715
CA341926377
206 S>G No ClinGen
TOPMed
gnomAD
rs1279666584
CA341926381
206 S>N No ClinGen
gnomAD
rs1366324309
CA341926398
207 Q>* No ClinGen
gnomAD
rs754226157
CA1090728
207 Q>H No ClinGen
ExAC
gnomAD
CA29564292
rs202077271
209 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1090729
rs202077271
209 E>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 210 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1090731
rs746429584
211 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs546112706
CA1090732
211 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA341926564
rs546112706
211 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs746429584
CA341926554
211 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA1090733
rs780019985
212 D>Y No ClinGen
ExAC
gnomAD
rs1488212650
CA341926616
212 D>G No ClinGen
gnomAD
CA1090734
rs780019985
212 D>N Variant assessed as Somatic; 4.625e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA341926662
rs1431728392
213 L>* No ClinGen
gnomAD
CA1090736
rs775375843
213 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs762721519
CA1090737
214 V>L No ClinGen
ExAC
gnomAD
CA341926755
COSM1222329
rs770774786
216 R>C large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA341926783
rs1422067003
216 R>H No ClinGen
gnomAD
CA1090738
rs770774786
216 R>S No ClinGen
ExAC
gnomAD
CA29564345
CA1090740
rs200407470
218 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs115063024
CA1090739
218 M>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1445295187
CA341926878
219 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs143739858
CA1090741
219 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1345813629
CA341927044
226 A>T No ClinGen
gnomAD
CA1090744
rs148730084
227 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA29564352
rs148730084
227 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs753602543
CA1090745
227 R>H No ClinGen
ExAC
gnomAD
rs1341248829
CA341927152
230 N>D No ClinGen
gnomAD
rs765709131
CA341927174
230 N>K No ClinGen
ExAC
TOPMed
gnomAD
rs762946987
CA1090746
230 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA341927188
rs1451044185
231 R>Q No ClinGen
gnomAD
CA341927394
rs957838632
CA341927393
233 Q>H No ClinGen
TOPMed
gnomAD
CA341927401
rs1571306510
234 I>L No ClinGen
Ensembl
CA341927423
rs540582656
234 I>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA341927405
rs4603
234 I>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
VAR_013115
rs4603
CA1090772
234 I>T No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs144372831
CA1090775
235 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
CA1090777
rs369317780
237 V>F No ClinGen
ESP
ExAC
TOPMed
CA1090780
rs144890599
239 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs764773921
CA1090784
241 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA1090782
rs374028323
241 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1090783
COSM1193857
rs374028323
241 G>S lung [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
rs1278314313
CA341927660
243 E>A No ClinGen
gnomAD
CA341927745
rs1199935822
245 E>D No ClinGen
TOPMed
rs1318046609
CA341927755
246 G>E No ClinGen
TOPMed
CA1090785
rs772971488
247 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs772971488
CA1090786
247 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs1438540752
CA341927944
252 T>S No ClinGen
gnomAD
CA341927963
rs1179124967
252 T>S No ClinGen
gnomAD
rs752003327
CA1090788
253 N>S No ClinGen
ExAC
gnomAD
rs1171659648
CA341928047
255 D>N No ClinGen
TOPMed
gnomAD
rs1403552029
CA341928058
255 D>V No ClinGen
gnomAD
CA29564567
rs142070497
256 I>T No ClinGen
ESP
rs867652139
CA29564579
257 A>D No ClinGen
Ensembl
CA1090789
rs1478575688
257 A>T No ClinGen
TOPMed
gnomAD
rs992948004
CA29564592
258 H>Y No ClinGen
TOPMed
gnomAD
rs767547580
CA1090792
259 M>I No ClinGen
ExAC
gnomAD
TCGA novel 260 I>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752746186
CA1090794
261 S>N No ClinGen
ExAC
rs752746186
CA341928283
261 S>T No ClinGen
ExAC
rs990120774
CA29564742
264 E>* No ClinGen
Ensembl

1 associated diseases with P28070

[MIM: 617591]: Proteasome-associated autoinflammatory syndrome 3 (PRAAS3)

An autoinflammatory disorder characterized by onset in early infancy and recurrent fever, nodular dermatitis, myositis, panniculitis-induced lipodystrophy, lymphadenopathy, and immune dysregulation. Variable accompanying features may include joint contractures, hepatosplenomegaly, anemia, thrombocytopenia, recurrent infections, autoantibodies, and hypergammaglobulinemia. Some patients may have intracranial calcifications. PRAAS3 inheritance is autosomal recessive or digenic. {ECO:0000269|PubMed:26524591}. Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry.

Without disease ID
  • An autoinflammatory disorder characterized by onset in early infancy and recurrent fever, nodular dermatitis, myositis, panniculitis-induced lipodystrophy, lymphadenopathy, and immune dysregulation. Variable accompanying features may include joint contractures, hepatosplenomegaly, anemia, thrombocytopenia, recurrent infections, autoantibodies, and hypergammaglobulinemia. Some patients may have intracranial calcifications. PRAAS3 inheritance is autosomal recessive or digenic. {ECO:0000269|PubMed:26524591}. Note=The disease is caused by variants affecting distinct genetic loci, including the gene represented in this entry.

1 regional properties for P28070

Type Name Position InterPro Accession
conserved_site Proteasome beta-type subunit, conserved site 57 - 104 IPR016050

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Nucleus
  • Translocated from the cytoplasm into the nucleus following interaction with AKIRIN2, which bridges the proteasome with the nuclear import receptor IPO9
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

10 GO annotations of cellular component

Name Definition
ciliary basal body A membrane-tethered, short cylindrical array of microtubules and associated proteins found at the base of a eukaryotic cilium (also called flagellum) that is similar in structure to a centriole and derives from it. The cilium basal body is the site of assembly and remodelling of the cilium and serves as a nucleation site for axoneme growth. As well as anchoring the cilium, it is thought to provide a selective gateway regulating the entry of ciliary proteins and vesicles by intraflagellar transport.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
proteasome complex A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core.
proteasome core complex A multisubunit barrel shaped endoprotease complex, which is the core of the proteasome complex.
proteasome core complex, beta-subunit complex The proteasome core subcomplex that constitutes the two inner rings of the proteasome core complex. An example of this component is found in Mus musculus.

1 GO annotations of molecular function

Name Definition
lipopolysaccharide binding Binding to a lipopolysaccharide.

3 GO annotations of biological process

Name Definition
negative regulation of inflammatory response to antigenic stimulus Any process that stops, prevents, or reduces the frequency, rate, or extent of an inflammatory response to an antigenic stimulus.
proteasomal protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome.
proteasome-mediated ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q3T108 PSMB4 Proteasome subunit beta type-4 Bos taurus (Bovine) PR
P28072 PSMB6 Proteasome subunit beta type-6 Homo sapiens (Human) PR
P99026 Psmb4 Proteasome subunit beta type-4 Mus musculus (Mouse) PR
P34067 Psmb4 Proteasome subunit beta type-4 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MEAFLGSRSG LWAGGPAPGQ FYRIPSTPDS FMDPASALYR GPITRTQNPM VTGTSVLGVK
70 80 90 100 110 120
FEGGVVIAAD MLGSYGSLAR FRNISRIMRV NNSTMLGASG DYADFQYLKQ VLGQMVIDEE
130 140 150 160 170 180
LLGDGHSYSP RAIHSWLTRA MYSRRSKMNP LWNTMVIGGY ADGESFLGYV DMLGVAYEAP
190 200 210 220 230 240
SLATGYGAYL AQPLLREVLE KQPVLSQTEA RDLVERCMRV LYYRDARSYN RFQIATVTEK
250 260
GVEIEGPLST ETNWDIAHMI SGFE